According to a story from Shawnee Mission Post, the nonprofit organization RareKC is working to support people with rare diseases that are living the Kansas City area. When living with…
According to a story from Oncology Times, a recent study indicates that the PARP inhibitor drug talazoparib could be an effective treatment option for patients with advanced, HER-2 negative, BRCA…
Based on a recent story by The Guardian, people living with lung cancer and ovarian cancer may soon have access to a new treatment option. The goal of the new…
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
